| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.1M | -15.9% |
| Cost of Revenue | $8.6M | -7.5% |
| Gross Profit | -$494K | -241.4% |
| R&D Expense | $186K | -41.7% |
| SG&A Expense | $1.9M | +14.7% |
| Operating Income | -$3.5M | -24.1% |
| Interest Expense | $435K | -19.8% |
| Pre-tax Income | -$4.0M | -16.9% |
| Net Income | -$4.0M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.0M | -58.2% |
| Accounts Receivable | $29K | -1.4% |
| Inventory | $2.9M | -11.7% |
| Current Assets | $6.0M | -34.4% |
| Total Assets | $17.8M | -21.5% |
| Current Liabilities | $12.7M | +21.2% |
| Total Liabilities | $13.5M | -18.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$410K | -63.9% |
| Capital Expenditures | $402K | -8.2% |
| Investing Cash Flow | -$402K | +8.2% |
| Financing Cash Flow | -$1.8M | -138.5% |
| Free Cash Flow | -$812K | -18.0% |
| -16.9% |
| EPS (Basic) | -$0.76 | -2.7% |
| EPS (Diluted) | -$0.76 | -2.7% |
| Stockholders' Equity |
| $4.3M |
| -28.7% |